Ozone therapy improves early stages of osseointegration in ovariectomized rats.

OBJECTIVE: the aim of this study was to analyze the influence of ozone therapy (OZN) on peri-implant bone repair in critical bones by installing osseointegrated implants in the tibia of ovariectomized rats. METHODOLOGY: ovariectomy was performed on 30 Wistar rats, aged six months (Rattus novergicus), and, after 90 days, osseointegrated implants were installed in each tibial metaphysis. The study groups were divided into the animals that received intraperitoneal ozone at a concentration of 700 mcg/kg - OZ Group (n=15) - and a control group that received an intraperitoneal saline solution and, for this reason, was named the SAL group (n=15). The applications for both groups occurred during the immediate post-operative period on the 2nd, 4th, 6th, 8th, 10th, and 12th day post-surgery. At various stages (14, 42, and 60 days), the animals were euthanized, and tests were performed on their tibiae. These tests include histomorphometric and immunohistochemical analyses, computerized microtomography, sampling in light-cured resin for calcified sections, and confocal microscopy. The obtained data were then analyzed using One-way ANOVA and the Shapiro-Wilk, Kruskal-Wallis, and student t-tests (P<0.05). RESULTS: our findings indicate that the OZ group (3.26±0.20 mm) showed better cellular organization and bone neoformation at 14 days (SAL group, 0.90±1.42 mm) (P=0.001). Immunohistochemistry revealed that osteocalcin labeling was moderate in the OZ group and mild in the SAL group at 14 and 42 days post-surgery. The data from the analysis of calcified tissues (microtomography, histometric, and bone dynamism analysis) at 60 days showed no statistically significant differences between the groups (P=0.32). CONCLUSION: it was concluded that ozone therapy anticipated the initial phases of the peri-implant bone repair process.

Ozone therapy improves early stages of osseointegration in ovariectomized rats

Abstract Objective the aim of this study was to analyze the influence of ozone therapy (OZN) on peri-implant bone repair in critical bones by installing osseointegrated implants in the tibia of ovariectomized rats. Methodology ovariectomy was performed on 30 Wistar rats, aged six months (Rattus novergicus), and, after 90 days, osseointegrated implants were installed in each tibial metaphysis. The study groups were divided into the animals that received intraperitoneal ozone at a concentration of 700 mcg/kg — OZ Group (n=15) — and a control group that received an intraperitoneal saline solution and, for this reason, was named the SAL group (n=15). The applications for both groups occurred during the immediate post-operative period on the 2nd, 4th, 6th, 8th, 10th, and 12th day post-surgery. At various stages (14, 42, and 60 days), the animals were euthanized, and tests were performed on their tibiae. These tests include histomorphometric and immunohistochemical analyses, computerized microtomography, sampling in light-cured resin for calcified sections, and confocal microscopy. The obtained data were then analyzed using One-way ANOVA and the Shapiro-Wilk, Kruskal-Wallis, and student t-tests (P<0.05). Results our findings indicate that the OZ group (3.26±0.20 mm) showed better cellular organization and bone neoformation at 14 days (SAL group, 0.90±1.42 mm) (P=0.001). Immunohistochemistry revealed that osteocalcin labeling was moderate in the OZ group and mild in the SAL group at 14 and 42 days post-surgery. The data from the analysis of calcified tissues (microtomography, histometric, and bone dynamism analysis) at 60 days showed no statistically significant differences between the groups (P=0.32). Conclusion it was concluded that ozone therapy anticipated the initial phases of the peri-implant bone repair process.

Cultura de células osteogênicas primárias a partir de osso de baixa densidade e análise do reparo ósseo periimplantar em ratas osteoporóticas em função da texturização de superfície por meio da oxidação por plasma eletrolítico / Primary cell culture from low-density bone and analysis periimplantar bone repair in osteoporotic rats as a function of surface texturing by electrolytic plasma oxidation

O objetivo deste estudo foi avaliar um novo método de texturização por PEO com incorporação de Ca e P na superfície do Ti-6Al-4V em ossos de baixa densidade, por meio de avaliação in vitro, ex-in vivo e in vivo, em função de parâmetros topográficos e reparacionais. 57 ratas Wistar (Rattus novergicus), sendo 38 ratas com 6 meses de idade (Grupos OXV - submetidas à ovariectomia e SHAM - cirurgia fictícia) e 19 ratas senis (18 meses de idade: Grupo SENIL), foram divididas para realização do estudo ex-in vivo (n=9) e in vivo (n=48). Os grupos para análise ex-in vivo foram submetidos à eutanásia e os fêmures foram removidos e transportados em meio de cultura contendo meio essencial mínimo modificação alfa (α- MEM) suplementado com 500 µg/mL de gentamicina e 3 µg/mL de fungisona. As células-tronco mesenquimais de medula óssea (CTMsMO) dos fêmures, foram isoladas e cultivadas em meio de crescimento para manterem-se como CTMs. Após alcançar a subconfluência, as células foram cultivadas em 3 superfícies de discos de Ti-6Al-4V, grupo CONTROLE (superfície usinada) grupo AC (superfície tratada por Ataque Ácido e Jateamento) e grupo PEO (superfície tratada por Oxidação de Plasma Eletrolítico com associação de Cálcio e Fosforo). Para avaliação das respostas celulares foram realizados ensaios de viabilidade celular, expressão gênica de marcadores osteoblásticos, imunolocalização de sialoproteina óssea (BSP) e osteopontina (OPN), atividade da fosfatase alcalina (ALP) e formação de matriz mineralizada. Os dados foram submetidos ao teste ANOVA 1 fator ou Kruskal-Wallis (p < 0,05). Nos experimentos in vivo, após 90 dias, foi instalado um implante em cada tíbia, sendo um implante pertencente ao grupo PEO e o outro implante do grupo AC. Após 42 dias da instalação dos implantes, 8 animais de cada grupo foram submetidos à eutanásia e suas tíbias passaram pela descalcificação, para a análise histológica e imunoistoquímica (OPG, RANKL, OC e TRAP). As demais ratas, após a eutanásia, tiveram suas tíbias coletadas e analisadas em microtomografia computadorizada (BV.TV, Tb.Th, Tb.N, Tb.Sp e Po(tot)) e, em seguida os implantes submetidos ao torque reverso em torquímetro digital (N.cm). A outra metade das tíbias foram processadas com inclusão em resina fotopolimerizadas para cortes calcificados e assim, a análise por microscopia confocal (calceina e alizarina) e em seguida, análise histométrica. Os dados foram submetidos ao teste ANOVA 1 fator ou Kruskal-Wallis, seguido de pós teste Tukey; p < 0,05). A análise da viabilidade celular mostrou que em todos os grupos testes de CTMs-MO para SHAM, OVX e SENIL apresentaram um crescimento progressivo nos diferentes tempos de 3, 7 e 10 dias. Avaliação da expressão gênica através dos genes Runx2, SP7/Osterix, ALP, BSP, OC e OPN e analise pela imunofluorecência apresentaram uma leve tendência de melhores respostas nas CTMs-MO SHAM para o grupo AC, CTMs-MO OVX para o grupo PEO e CTMsMO SENIS características semelhantes nos grupos AC e PEO. A atividade da fosfatase alcalina ocorreu maior expressão na superfície PEO no grupo SHAM, maior expressão na superfície CONTROLE no grupo OVX e no grupo SENIL houve um equilíbrio em todas as superfícies. A superfície PEO apresentou maior formação de nódulos de mineralização (21º dia) em todos os grupos. Nos experimentos in vivo, as análises histológicas mostrou maior neoformação óssea no grupo PEO quando comparado ao grupo AC nos grupos SHAM e OVX, e no grupo SENIL foram similares os resultados. A avaliação imunoistoquímica demonstrou um equilíbrio em todos os grupos na comparação de superfícies na proteína TRAP, para o processo de remodelação (OPG e RANKL) e mineralização (OC) nos grupos SHAM e SENIL (p>0,05), ocorrendo uma diminuição no grupo OVX, no qual os resultados do PEO foram mais favoráveis que AC nessa conformação. Na análise microtomográfica, BV.TV os resultados foram semelhantes em ambos os grupos, porém em OVX AC mostrou menor porcentagem de volume ósseo e uma maior porosidade (Po(tot)). A análise biomecânica por torque-reverso (N.cm) mostrou que os maiores valores pertenciam ao grupo PEO. A dinâmica do tecido ósseo representada pelo turnover ósseo, observado através dos fluorocromos (Calceína e Alizarina) mostrou-se similares nos grupos experimentais. As superficies PEO E AC nesse estudo demonstram que possuem uma grande capacidade de promoção da formação óssea independente dos tipos ósseos experimentais (SHAM, OVX e SENIL), tanto na área de contato osso e implante (ELCOI), quanto para a área de osso neoformado (AON). Diante daslimitações do estudo in vitro e in vivo, os resultados foram esclarecedores para acreditar que o método de texturização aqui testado, por meio da Oxidação por Plasma Eletrolítico (PEO), favoreceu à formação óssea, principalmente nos ossos mais críticos (OVX), inclusive evidenciando maior maturação óssea nos períodos mais tardios aqui analisados(AU)

The objective of this study was to evaluate a new PEO texturing method with Ca and P incorporation on the Ti-6Al-4V surface in low bone density, by means of in vitro, ex vivo and in vivo evaluation through topographic and repairment parameters. 57 Wistar rats (Rattus novergicus), being 38 at 6 months of age (OXV Groups - submitted to ovariectomy and SHAM surgery) and 19 senile rats (18 months of age: SENIL Group) were divided into three subgroups: ex-in vivo (n = 9) and in vivo (n = 48). The Groups for ex-in vivo analysis were euthanized and femurs were removed and transported in culture medium containing minimal alpha modification (α- MEM) medium supplemented with 500 µg / ml gentamicin and 3 µg / ml fungizone. The mesenchymal stem cells from bone marrow (MSC-M) of the femur were isolated and cultured in growth medium to remain as MSCs. After reaching the subconfluence, the cells were grown on 3 surfaces of Ti-6Al-4V discs, CONTROL group (machined surface) group AC (surface treated by etched-acid) and PEO group (surface treated by Electrolytic Plasma Oxidation with the association of Calcium and Phosphorus). Cell viability assays, gene expression of osteoblastic markers, bone sialoprotein (BSP) and osteopontin (OPN), alkaline phosphatase (ALP) activity, and mineralized matrix formation were performed to evaluate cellular responses. Data were submitted to ANOVA 1 factor test or Kruskal-Wallis test (P <0.05). In the groups for the in vivo study, after 90 days, an implant was installed on each tibia, one implant to the PEO group and another implant of the AC group. After 42 days of implant implantation, eight animals from each group underwent euthanasia and their tibiae underwent decalcification for histological and immunohistochemical analysis (OPG, RANKL, OC, and TRAP). The other rats, after euthanasia, had their tibiae collected and analyzed in computerized microtomography (BV.TV, Tb.Th, Tb.N, Tb.Sp and Po (tot)), and then implants submitted to reverse torque in Digital torque wrench (N.cm). Another half of the tibiae were processed with inclusion in photopolymerized resin for calcified cuts and thus the analysis by confocal microscopy (calcein and alizarin) and then histometric analysis. Data were submitted to 1-factor ANOVA or Kruskal-Wallis test, followed by Tukey test; p <0.05). The cell viability analysis showed that in all groups, MOH tests for SHAM, OVX, and SENIL showed a progressive growth in the different times of 3, 7 and 10 days. Evaluation of gene expression through the Runx2, SP7 / Osterix, ALP, BSP, OC and OPN genes and immunofluorescence analysis showed a slight tendency for better responses in the CTMs- MO SHAM for the AC group, CTMs-MO OVX for the PEO group and CTMs-MO SENIS features similar in AC and PEO groups. The alkaline phosphatase activity was higher on the PEO surface in the SHAM group, the greater expression on the CONTROL surface in the OVX group and the SENIL group showed a balance on all surfaces. The PEO surface presented a higher formation of mineralization nodules in all groups (21st day). For the in vivo analyzes, the histological analysis showed greater bone neoformation in the PEO group when compared to the AC group in the SHAM and OVX groups, and in the SENIL group, the results were similar. The immunohistochemical evaluation showed a balance in all groups in the comparison of surfaces in the TRAP protein, for the remodeling process (OPG and RANKL) and mineralization (OC) in the SHAM and SENIL groups (p> 0.05). OVX group, in which PEO results were more favorable than AC in this confirmation. In the microtomographic analysis, BV.TV the results were similar in both groups, but in OVX AC showed a lower percentage of bone volume and a higher porosity (Po (tot)). Biomechanical analysis by torque-reverse (N.cm) showed that the highest values belonged to the PEO group. The dynamics of the bone tissue represented by the bone turnover observed through the fluorochromes (Calcein and Alizarin) were similar in the experimental groups. The PEO and AC surfaces in this study demonstrate that they have a great ability to promote bone formation independent of experimental bone types (SHAM, OVX, and SENIL), both in the area of bone and implant contact (ELCOI) and in the area of newly formed bone (AON). Considering the limitations of the in vitro and in vivo study, the results were enlightening to believe that the texturing method tested here, through Electrolytic Plasma Oxidation (PEO), favored bone formation, mainly in the most critical bones (OVX), including evidence of increased bone maturation in the later periods analyzed here(AU)

Inflammatory Myofibroblastic Tumor: Rare Manifestation in Face.

Inflammatory myofibroblastic tumor, also known as inflammatory pseudotumor and plasma cell granuloma, is a tumor that occurs most often in the lungs, abdomen, skin, soft tissue, genital system, and mediastinal. Before surgery, the diagnosis is difficult to establish because of its diverse manifestations. In the head and neck, manifestation is rare and may occur in the upper respiratory tract, soft tissues, orbits, and skull base. This article aims to report a rare manifestation of the disease in the face, highlighting the importance of a correct diagnosis to determine the most appropriate form of treatment, in male patient, leucoderma, 22 years old, with complain of a painless unilateral growth in the left cheek, beginning 2 months before and with progressive growth.

Simultaneous Occurrence of Central Giant Cell Granuloma and Odontogenic Keratocyst in Mandible.

Odontogenic keratocysts and central giant cell granulomas are distinct entities of separate origin that may appear simultaneously in the jaw, making them difficult to differentiate. The objectives of this paper are to report a case of a 54-year-old man presenting with a large lesion in the right mandible and to describe the histological characteristics of that lesion. Imaging revealed tumefaction and multilobulation. The case was surgically managed. Histopathological examination revealed that the lesion was a hybrid of an odontogenic keratocyst and a central giant cell granuloma. It remains unclear as to whether this lesion represented a coincidental or related injury. Since both types of lesion involved have a high rate of recurrence, however, long-term follow-up is scheduled.

Non-familial Cherubism – Report of a case / Querubim não familiar - Relatório de caso

The Cherubism is a rare disease that affects the middle and lower third of the facein individuals at the time of childhood. It is a rarehereditary benign bone disease with an autosomal dominant inheritance. The familial distribution may affect different generations and isolated nonfamilial cases have also been reported in literature. Lesions appear as cystic multilocular radiolucencies, histologically, they resemble central giant cell granluloma and hyperpara thyroidism brown tumorwith numerous randomly distributed multinuclea tedgiant cells and vascular spaces within a fibrous connective tissue stroma. Objective: The aim of this study is to report the importance of the diagnosis of this pathology and the variety of treatments availablein the literature, thus guiding to an individualized treatment. Case Report: Caucasian 8 years-oldfemale, in good general condition, was referred to Service of Oral and Maxillofacial Surgery of Erasto Gaertner Hospital (EGH), Curitiba – PR, Brazil, complaining of bilateral swelling of the maxilla and mandible since 4 years-old. Apparently, the girl isthe first one who developed the genetic pathologyin at least 4 generations of her family. After biopsy, cherubism diagnosis was confirmed and the treatment of choice was periodic monitoring. Discussion: Cherubism studies with long-term follow-up with clinical and radiographic documentation indicate that the spontaneous resolution of bone lesions israre. Treatment of cherubism is controversial and various modalities have been reported as the use of calcitonin, osseous plasty surgery, curettage, orthognathic surgery, liposuction and palliative treatments. Conclusion: cherubism is a rarecondition that affects individuals in childhood that lead to some facial alterations, those patients need an special care and an well trained team to treat these disease more carefully and wisely noting that exist a series of option of new treatments in this cases...

Introdução: O Querubismo é uma doença rara que afeta o terço médio e inferior da face em indivíduos no momento da infância. É uma doença óssea hereditária benigna com herança autossômica dominante sendo que a distribuição familial pode afetar diferentes gerações, todavia casos não-familiares isolados também foram relatados na literatura. As lesões apresentam se radiograficamente como cistos multiloculados radiolúcidos e histologicamente se assemelham ao granuloma central de células gigantes e ao tumor marrom do hiper paratireoidismo com numerosas células gigantes multinucleadas distribuídos aleatoriamente e espaços vasculares dentro de um estroma de tecido conjuntivo fibroso. Objetivos: O objetivo deste estudo é relatar a importância do diagnóstico desta patologia e da variedade de tratamentos disponíveis na literatura, orientando dessa maneira a um tratamento individualizado. Relato de Caso: Mulher, caucasiana, 8 anos de idade, em bom estado geral. Foi encaminhada ao Serviço de Cirurgia Bucomaxilofacial do Hospital Erasto Gaertner (EGH), Curitiba - PR, Brasil, com queixa de inchaço bilateral da maxila e da mandíbula desde os 4 anos de idade. Em avaliação notou-se que menina é a primeira pessoa que desenvolveu a patologia empelo menos quatro gerações de sua família. Após biópsia o diagnóstico de cherubism foi confirmado e o tratamento de escolha foi a monitorização periódica. Discussão: estudos de cherubism a longo prazo de follow-up com documentação clínica e radiográficas indicam que a resolução espontânea das lesões ósseas são raras. O tratamento do cherubism é controverso e diversas modalidades têm sido relatados como o uso de calcitonina, a cirurgia de plastia óssea, curetagem cirurgia ortognática, lipoaspiração e tratamentos paliativos...

Implications of the use of bisphosphonates in dental treatment - experience of the service of oral and maxillofacial surgery, Erasto Gaertner Hospital, Curitiba, Brazil

Introduction: Bisphosphonates (BP) are effective drugs in the prevention and treatment of various bone pathologies, acting in the regulation of osteoclast function through different mechanisms. Despite the success in the treatment of various diseases, these drugs have the ability to induce an avascular necrosis of bone tissue, especially in the maxilla and mandible. Objective: Due the significant increase number of cases of patients with oral complications associated with BP therapy in the Department of Oral and Maxillofacial Surgery of the Erasto Gaertner Hospital, the study aimed to report our experience in the care of these patients. Material and methods: Patients submitted to BP therapy were enrolled prospectively between the years of 2011 and 2012. Clinical examination was performed in all patients to evaluate dental health as well oral mucosa. All patients are under follow-up in our service. Results: 26 patients who used BP were attended in the ambulatory. Twenty-three patients used BP for oncological indication and three for osteoporosis. Most of patients were women (6666%) with average age of 56 years old. The most frequent medication used was Pamidronate (54%), followed by Zoledronic acid (30%) and Alendronate (15%). Ten patients showed bone exposition, most of then in the mandible (80%), with an average time of one year of exposure. Conclusion: Dentists should advise their patients about the use of BP and the implications for oral health and treatments. These patients must have periodic consultations for evaluation and early detection of osteonecrosis associated to BP for adequate treatment.